Depreciation, Depletion and Amortization of WEST PHARMACEUTICAL SERVICES INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary: WEST PHARMACEUTICAL SERVICES INC quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
WEST PHARMACEUTICAL SERVICES INC Depreciation, Depletion and Amortization for the quarter ending 31 Dec 2025 was $47,000,000, a 15% increase year-over-year.
WEST PHARMACEUTICAL SERVICES INC Depreciation, Depletion and Amortization for the twelve months ending 31 Dec 2025 was $171,400,000, a 10% increase year-over-year.
WEST PHARMACEUTICAL SERVICES INC annual Depreciation, Depletion and Amortization for 2025 was $171,400,000, a 10% increase from 2024.
WEST PHARMACEUTICAL SERVICES INC annual Depreciation, Depletion and Amortization for 2024 was $155,400,000, a 13% increase from 2023.
WEST PHARMACEUTICAL SERVICES INC annual Depreciation, Depletion and Amortization for 2023 was $137,300,000, a 14% increase from 2022.
Source SEC data: View on sec.gov

Depreciation, Depletion and Amortization, Trailing 12 Months (USD)

Depreciation, Depletion and Amortization, Quarterly (USD)

Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

Depreciation, Depletion and Amortization, Annual (USD)

Depreciation, Depletion and Amortization, YoY Annual Change (%)

WEST PHARMACEUTICAL SERVICES INC Quarterly Depreciation, Depletion and Amortization (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$171,400,000	$47,000,000	+$6,300,000	+15%	01 Oct 2025	31 Dec 2025	10-K	17 Feb 2026	2025	FY
Q3 2025	$165,100,000	$43,000,000	+$2,800,000	+7%	01 Jul 2025	30 Sep 2025	10-Q	23 Oct 2025	2025	Q3
Q2 2025	$162,300,000	$41,400,000	+$2,500,000	+6.4%	01 Apr 2025	30 Jun 2025	10-Q	24 Jul 2025	2025	Q2
Q1 2025	$159,800,000	$40,000,000	+$4,400,000	+12%	01 Jan 2025	31 Mar 2025	10-Q	24 Apr 2025	2025	Q1
Q4 2024	$155,400,000	$40,700,000			01 Oct 2024	31 Dec 2024	10-K	17 Feb 2026	2025	FY
Q3 2024		$40,200,000			01 Jul 2024	30 Sep 2024	10-Q	23 Oct 2025	2025	Q3
Q2 2024		$38,900,000			01 Apr 2024	30 Jun 2024	10-Q	24 Jul 2025	2025	Q2
Q1 2024		$35,600,000			01 Jan 2024	31 Mar 2024	10-Q	24 Apr 2025	2025	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$171,400,000	+$16,000,000	+10%	01 Jan 2025	31 Dec 2025	10-K	17 Feb 2026	2025	FY
2024	$155,400,000	+$18,100,000	+13%	01 Jan 2024	31 Dec 2024	10-K	17 Feb 2026	2025	FY
2023	$137,300,000	+$16,700,000	+14%	01 Jan 2023	31 Dec 2023	10-K	17 Feb 2026	2025	FY
2022	$120,600,000	-$1,700,000	-1.4%	01 Jan 2022	31 Dec 2022	10-K	18 Feb 2025	2024	FY
2021	$122,300,000	+$13,200,000	+12%	01 Jan 2021	31 Dec 2021	10-K	20 Feb 2024	2023	FY
2020	$109,100,000	+$5,700,000	+5.5%	01 Jan 2020	31 Dec 2020	10-K	21 Feb 2023	2022	FY
2019	$103,400,000	-$1,000,000	-0.96%	01 Jan 2019	31 Dec 2019	10-K	22 Feb 2022	2021	FY
2018	$104,400,000	+$7,700,000	+8%	01 Jan 2018	31 Dec 2018	10-K	23 Feb 2021	2020	FY
2017	$96,700,000	+$6,000,000	+6.6%	01 Jan 2017	31 Dec 2017	10-K	24 Feb 2020	2019	FY
2016	$90,700,000	+$800,000	+0.89%	01 Jan 2016	31 Dec 2016	10-K	28 Feb 2019	2018	FY
2015	$89,900,000	-$100,000	-0.11%	01 Jan 2015	31 Dec 2015	10-K	26 Feb 2018	2017	FY
2014	$90,000,000	+$4,800,000	+5.6%	01 Jan 2014	31 Dec 2014	10-K	28 Feb 2017	2016	FY
2013	$85,200,000	+$8,300,000	+11%	01 Jan 2013	31 Dec 2013	10-K	26 Feb 2016	2015	FY
2012	$76,900,000	+$1,200,000	+1.6%	01 Jan 2012	31 Dec 2012	10-K	25 Feb 2015	2014	FY
2011	$75,700,000	+$2,500,000	+3.4%	01 Jan 2011	31 Dec 2011	10-K	27 Feb 2014	2013	FY
2010	$73,200,000			01 Jan 2010	31 Dec 2010	10-K	27 Feb 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.